| AMGOX | FSMAX | AMGOX / FSMAX | |
| Total Expense Ratio | 0.94 | 0.04 | 2,686% |
| Annual Report Gross Expense Ratio | 0.97 | 0.04 | 2,771% |
| Fund Existence | 33 years | 14 years | - |
| Gain YTD | 11.961 | 11.598 | 103% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 500000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 156M | 41.5B | 0% |
| Annual Yield % from dividends | 0.00 | 0.43 | - |
| Returns for 1 year | 7.99 | 6.78 | 118% |
| Returns for 3 years | 53.49 | 53.30 | 100% |
| Returns for 5 years | -30.49 | 44.78 | -68% |
| Returns for 10 years | 18.34 | 108.36 | 17% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BIDEX | 11.47 | -0.04 | -0.35% |
| BlackRock Defensive Advantage EM Instl | |||
| LAFRX | 20.80 | -0.30 | -1.42% |
| Lord Abbett Affiliated R3 | |||
| MUEUX | 40.72 | -0.64 | -1.55% |
| MFS Blended Research Core Equity R4 | |||
| RIVBX | 36.80 | -0.64 | -1.71% |
| Riverbridge Growth Institutional | |||
| CCSMX | 23.56 | -0.42 | -1.75% |
| Conestoga SMid Cap Investors | |||